PAVM PAVmed Inc. Stock Quote

PAVM [NASD]

Index	-	P/E	-	EPS (ttm)	-0.74	Insider Own	5.00%	Shs Outstand	82.46M	Perf Week	20.72%
Market Cap	485.70M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	-4.23%	Shs Float	72.01M	Perf Month	57.07%
Income	-34.60M	PEG	-	EPS next Q	-0.12	Inst Own	10.90%	Short Float	7.60%	Perf Quarter	173.97%
Sales	-	P/S	-	EPS this Y	-31.50%	Inst Trans	29.77%	Short Ratio	1.14	Perf Half Y	214.14%
Book/sh	-0.01	P/B	-	EPS next Y	34.10%	ROA	-280.60%	Target Price	8.50	Perf Year	209.28%
Cash/sh	0.22	P/C	27.75	EPS next 5Y	-	ROE	293.90%	52W Range	1.63 - 6.59	Perf YTD	183.02%
Dividend	-	P/FCF	-	EPS past 5Y	-35.80%	ROI	-	52W High	-9.26%	Beta	0.36
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	-	Gross Margin	-	52W Low	266.87%	ATR	0.54
Employees	25	Current Ratio	0.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	66.65	Volatility	12.18% 11.24%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	12.70%	Profit Margin	-	Rel Volume	0.46	Prev Close	6.00
Shortable	Yes	LT Debt/Eq	-	Earnings	Feb 22 AMC	Payout	-	Avg Volume	4.81M	Price	5.98
Recom	2.00	SMA20	26.31%	SMA50	48.66%	SMA200	140.64%	Volume	1,988,300	Change	-0.33%

Mar-30-21

Initiated

Cantor Fitzgerald

Overweight

Nov-05-20

Initiated

Ascendiant Capital Markets

Buy

Jun-28-18

Initiated

Maxim Group

Buy

Apr-08-21 09:30AM	PAVmed to Present at the 20th Annual Needham Healthcare Conference GlobeNewswire
Mar-10-21 09:30AM	PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference GlobeNewswire
Mar-03-21 09:30AM	PAVmed Retires Convertible Debt GlobeNewswire
Mar-01-21 09:30AM	PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors GlobeNewswire
Feb-25-21 12:37PM	PAVmed Announces Closing of its Public Offering of Common Stock GlobeNewswire
Feb-23-21 09:00AM	PAVmed Announces Pricing of $45 Million Public Offering of Common Stock GlobeNewswire -19.64%
07:25AM	The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga
Feb-22-21 04:13PM	PAVmed Announces Proposed Public Offering of Common Stock GlobeNewswire +21.44%
08:18AM	PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results GlobeNewswire
Feb-18-21 09:30AM	PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST GlobeNewswire -6.73%
Feb-16-21 09:30AM	First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmeds CarpX® Device GlobeNewswire +28.29%
Feb-11-21 08:30AM	Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 PR Newswire +19.78%
Feb-09-21 09:30AM	PAVmed to Hold Business Update Conference Call on February 22, 2021 GlobeNewswire +10.27%
Jan-08-21 10:53AM	PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire
Jan-06-21 09:29AM	PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules GlobeNewswire -15.50%
Dec-22-20 12:04PM	PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering GlobeNewswire
Dec-18-20 09:29AM	PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering GlobeNewswire
Dec-16-20 02:53AM	What Type Of Shareholders Make Up PAVmed Inc.'s (NASDAQ:PAVM) Share Registry? Simply Wall St.
Dec-11-20 09:29AM	PAVmed Announces Registered Direct Offering of its Common Stock GlobeNewswire
Nov-30-20 09:15PM	Is PAVmed Inc. (PAVM) A Good Investment Now? Insider Monkey
Nov-17-20 04:00PM	PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
02:45PM	PAVmed, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-20 09:30AM	PAVmed to Hold Business Update Conference Call on November 17, 2020 GlobeNewswire
Oct-06-20 07:30AM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating PAVmed Inc. for Potential Breach of Fiduciary Duty Claims ACCESSWIRE
Sep-08-20 09:30AM	PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020 GlobeNewswire
Aug-27-20 09:30AM	PAVmed to Present at The LD 500 Virtual Conference ACCESSWIRE
Aug-18-20 04:14PM	PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-06-20 09:27AM	PAVmed Secures $7 Million Convertible Note Financing GlobeNewswire
Aug-05-20 09:00AM	LD Micro Announces Preliminary List of Presenters for the LD-500 ACCESSWIRE
Jul-28-20 09:30AM	PAVmed to Hold Business Update Conference Call on August 18, 2020 GlobeNewswire
Jul-14-20 11:11PM	Edited Transcript of PAVM earnings conference call or presentation 21-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jul-13-20 09:30AM	PAVmed to Present at Maxim Groups COVID-19 Webinar on July 16, 2020 GlobeNewswire
Jul-07-20 12:15PM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating PAVmed Inc. for Potential Breach of Fiduciary Duty Claims ACCESSWIRE
Jun-17-20 09:30AM	PAVmed to Join the Russell 2000® and Russell 3000® Indexes GlobeNewswire +10.14%
Jun-15-20 09:30AM	Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor GlobeNewswire +17.53%
07:30AM	ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors GlobeNewswire
Jun-11-20 09:30AM	PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard Esophageal DNA Test GlobeNewswire
Jun-03-20 09:30AM	PAVmed Collaborates with Canon on DisappEAR Pediatric Ear Tubes GlobeNewswire
May-27-20 05:08PM	Should You Buy PAVmed Inc. (PAVM)? Insider Monkey
May-21-20 04:00PM	PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
02:30PM	PAVmed, Inc. to Host Earnings Call ACCESSWIRE
May-11-20 09:30AM	PAVmed to Hold Business Update Conference Call on May 21, 2020 GlobeNewswire
Apr-22-20 10:12AM	Company News for Apr 22, 2020 Zacks
Apr-21-20 09:30AM	PAVmed Receives FDA 510(k) Clearance for its CarpX Minimally Invasive Carpal Tunnel Device GlobeNewswire +15.42%
Apr-20-20 07:05PM	Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT Thomson Reuters StreetEvents -6.58%
Apr-09-20 04:44PM	PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
02:30PM	PAVmed, Inc. to Host Earnings Call ACCESSWIRE
Apr-02-20 09:30AM	PAVmed Subsidiary Lucid Diagnostics EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award GlobeNewswire
Mar-31-20 09:30AM	PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing GlobeNewswire +8.79%
Mar-24-20 09:30AM	PAVmed to Hold Business Update Conference Call on April 9, 2020 GlobeNewswire +21.74%
Mar-09-20 09:30AM	PAVmed Announces FDA 510(k) Re-submission for its CarpX Minimally Invasive Carpal Tunnel Device GlobeNewswire
Mar-02-20 09:30AM	PAVmed Subsidiary Lucid Diagnostics Partners with University of Pennsylvania to Evaluate EsoCheck in Eosinophilic Esophagitis (EoE) Patients GlobeNewswire +8.60%
Feb-20-20 09:30AM	PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barretts Esophagus (BE) Progression Biomarkers Using EsoCheck GlobeNewswire
Feb-18-20 09:30AM	PAVmed Adds EsoCure Esophageal Ablation Device with Patented Caldus Technology to Commercial Product Pipeline GlobeNewswire
Feb-12-20 09:18AM	The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga +7.69%
Feb-11-20 09:30AM	U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test GlobeNewswire +14.97%
Jan-14-20 07:55AM	The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga
Jan-13-20 09:30AM	PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance GlobeNewswire -7.79%
Dec-19-19 09:30AM	PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test GlobeNewswire
Dec-16-19 06:16PM	Edited Transcript of PAVM earnings conference call or presentation 21-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-13-19 09:30AM	PAVmed Provides Update on CarpX Clinical Safety Study GlobeNewswire +9.41%
Nov-29-19 10:37PM	Is PAVmed Inc. (PAVM) A Good Stock To Buy? Insider Monkey
Nov-21-19 04:00PM	PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.18%
Nov-14-19 09:30AM	PAVmed Partners with Laser Technology Pioneer Dr. Jacob Wong to Develop and Commercialize Non-Invasive Laser-based Diagnostic Products GlobeNewswire
Nov-07-19 09:30AM	PAVmeds PortIO Intraosseous Infusion System Achieves Multiple Milestones GlobeNewswire
Nov-06-19 09:30AM	PAVmed to Hold Business Update Conference Call on November 21, 2019 GlobeNewswire
Nov-05-19 07:00AM	PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization GlobeNewswire
Sep-20-19 05:43AM	Edited Transcript of PAVM earnings conference call or presentation 5-Sep-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-05-19 09:30AM	PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Aug-21-19 09:30AM	USPTO Grants PAVmed Patent Covering its CarpX Device GlobeNewswire
Aug-15-19 09:30AM	PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX 510(k) Re-submission GlobeNewswire
Aug-07-19 09:30AM	PAVmed to Hold Business Update Conference Call on September 5, 2019 GlobeNewswire
Jul-18-19 03:39PM	What Kind Of Shareholder Appears On The PAVmed Inc.'s (NASDAQ:PAVM) Shareholder Register? Simply Wall St.
Jun-26-19 09:30AM	PAVmed to Join Russell Microcap® Index GlobeNewswire
Jun-24-19 10:46AM	PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck GlobeNewswire
Jun-13-19 09:18AM	Edited Transcript of PAVM earnings conference call or presentation 21-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-21-19 09:30AM	PAVmed Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.48%
May-20-19 09:30AM	PAVmed Announces First Human CarpX Procedures GlobeNewswire
May-06-19 09:30AM	PAVmed to Hold Business Update Conference Call on May 21, 2019 GlobeNewswire
Apr-24-19 09:30AM	PAVmed Reports Excellent DisappEAR Animal Study Results GlobeNewswire
Apr-12-19 09:35AM	PAVmed Announces Registered Direct Offering of its Common Stock GlobeNewswire -8.80%
Apr-04-19 12:25PM	Investors Who Bought PAVmed (NASDAQ:PAVM) Shares A Year Ago Are Now Down 32% Simply Wall St.
09:30AM	PAVmed Reports Fourth Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Mar-21-19 07:30AM	PAVmed to Hold Business Update Conference Call on April 4, 2019 GlobeNewswire
Mar-20-19 07:30AM	PAVmed Announces NextFlo Breakthrough GlobeNewswire
Mar-13-19 08:04AM	PAVmed Announces PortIO Breakthrough GlobeNewswire
Feb-28-19 12:49PM	PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer GlobeNewswire
Feb-26-19 07:30AM	PAVmed Provides Business Update GlobeNewswire
Jan-10-19 07:30AM	PAVmed Provides Business Update GlobeNewswire -14.66%
Dec-17-18 07:00AM	Stonegate Capital Partners Initiates Coverage on PAVmed, Inc. (PAVM) ACCESSWIRE
Nov-29-18 02:29PM	How Much Money Does PAVmed Inc (NASDAQ:PAVM) Make? Simply Wall St.
07:30AM	PAVmed Subsidiary Lucid Diagnostics Files 510(k) Submission with FDA for EsoCheck Cell Collection Device GlobeNewswire
Nov-19-18 08:45AM	Consolidated Research: 2018 Summary Expectations for Moleculin Biotech, Novan, PAVmed, Maui Land & Pineapple, Hallmark Financial Services, and McEwen Mining Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-15-18 07:30AM	PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-01-18 07:30AM	PAVmed to Hold Business Update Conference Call on November 15, 2018 GlobeNewswire
Oct-23-18 07:30AM	PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference GlobeNewswire
Oct-17-18 07:30AM	PAVmed Provides Business Update GlobeNewswire +6.14%
Sep-25-18 12:49PM	Is PAVmed Incs (NASDAQ:PAVM) Balance Sheet A Threat To Its Future? Simply Wall St. +5.47%
Aug-23-18 09:06AM	Benzinga Pro's 5 Stocks To Watch Today Benzinga -19.57%
Aug-14-18 07:30AM	PAVmed Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Aklog Lishan	Chairman and CEO	Mar 18	Buy	4.31	7,500	32,324	1,105,913	Mar 19 01:07 PM
SIROVICH MATTHEW	10% Owner	Nov 25	Sale	1.96	33,203	65,048	1,027,744	Nov 27 03:07 PM
SIROVICH MATTHEW	10% Owner	Nov 24	Sale	2.00	53,036	105,876	1,060,947	Nov 27 03:07 PM
SIROVICH MATTHEW	10% Owner	Nov 19	Sale	1.83	75,211	137,418	1,113,983	Nov 20 01:01 PM
SIROVICH MATTHEW	10% Owner	Nov 18	Sale	1.78	24,789	44,164	1,189,194	Nov 20 01:01 PM
SIROVICH MATTHEW	10% Owner	May 29	Sale	1.98	131,082	259,477	1,213,983	Jun 01 01:18 PM
SIROVICH MATTHEW	10% Owner	May 28	Sale	2.06	69,839	143,666	1,345,065	Jun 01 01:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience